NUPLAZID

Serial Number 86886134
Registration 5097134
702

Registration Progress

Application Filed
Jan 26, 2016
Under Examination
Aug 9, 2016
Approved for Publication
Jun 14, 2016
Published for Opposition
Jun 14, 2016
Registered
Dec 6, 2016

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161206)
Due: Dec 06, 2026 341 days

Trademark Image

NUPLAZID

Basic Information

Serial Number
86886134
Registration Number
5097134
Filing Date
January 26, 2016
Registration Date
December 6, 2016
Published for Opposition
June 14, 2016
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Apr 4, 2023
Registration
Registered
Classes
005

Rights Holder

ACADIA Pharmaceuticals Inc.

03
Address
12830 El Camino Real, Suite 400
San Diego, CA 92130

Ownership History

ACADIA Pharmaceuticals Inc.

Original Applicant
03
San Diego, CA

ACADIA Pharmaceuticals Inc.

Owner at Publication
03
San Diego, CA

ACADIA Pharmaceuticals Inc.

Original Registrant
03
San Diego, CA

Legal Representation

Attorney
Brian Focarino

USPTO Deadlines

Next Deadline
341 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161206)
Due Date
December 06, 2026
Grace Period Ends
June 06, 2027

Application History

31 events
Date Code Type Description Documents
Dec 6, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 12, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 4, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Apr 4, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 4, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 23, 2022 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 6, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 21, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 21, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 21, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 21, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 21, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 6, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 2, 2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 1, 2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 1, 2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 11, 2016 IUAF S USE AMENDMENT FILED Loading...
Oct 27, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 11, 2016 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 9, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 14, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 14, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 25, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 12, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 11, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2016 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 29, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
First Use Anywhere: May 31, 2016
First Use in Commerce: May 31, 2016

Additional Information

Design Mark
The mark consists of the wording "NUPLAZID" in stylized letters with a triangle forming the dot over the letter "I".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005